Florbetapir F-18 (AV-45)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Florbetapir F-18 (AV-45), covering 2013-03-28 to 2013-03-28. Get the full timeline:
Most recent: Clinical Trial Update: Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45) [Phase 2]